ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Twinrix 720/20, Injektionssuspension - 10
00592004 GlaxoSmithKline AG
Twinrix 720/20, Injektionssuspension12.12.1996
  12.12.1996
Combinations (J07BC20) 
WHO-DDD 
08.08.10
08.08. 
B  
No 
IP 
PR  
k.A.PR
  
7680005920041Impfstoffe
  
Composition
hepatitis-A-virus inactivatus (HM175) 720 U., hepatitidis B viri antigenum ADNr 20 µg, aluminium 0.45 mg ut aluminii phosphas et aluminii hydroxidum hydricum ad adsorptionem, natrii chloridum corresp. natrium 3.46 mg, aqua ad iniectabile q.s. ad suspensionem pro 1 ml, residui: aminoacida cum phenylalaninum, formaldehydum, neomycini sulfas, polysorbatum 20.
Packungsbestandteile
Injection suspension
 
 
Active AgentDose
Hepatitidis b viri Antigenum Adnr20 µg/ml
Hepatitis-A-Virus Inactivatus (Hm175)720 U/ml
 
Inactive agentsDose
Aluminii Hydroxidum Hydricum ad Adsorptionem 
Alumine0.45 mg/ml
Sodium Chloride 
Source
Data was imported : 06.02.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home